A downtown apartment building's owners point to rising nearby crime incidents in seeking to extend a 100% property tax ...

Researchers monitoring for larger .ICS calendar attachments found that a flaw in Zimbra Collaboration Suite (ZCS) was used in ...

Keenan Allen may not be seen as an NFL superstar but after breaking a 19-year record, NFL experts tell the BBC why he should ...

On 13 October 2025, Treasury announced changes to the proposed Better Targeted Superannuation Concessions. These proposed ...

From invalid codes to missing return tags, discover the key hreflang errors that break international SEO and how to avoid ...

While Kim Crawford Sauvignon Blanc continues to represent New Zealand wine around the world with telltale zesty and jubilant ...

Injuries are an inevitable part of the NFL with all the high-speed collisions, crushing hits and high exertion necessary on ...

Professor Watson’s entire career has involved breaking down barriers or challenging the norms within the legal profession.

Ken’s search for answers brought him to nearly a dozen doctors. After months of tests, he was finally diagnosed with a rare ...

"As a multisystem disease, it is well-known that ATTR-CM impacts more than just the heart," said Marcus Urey, M.D., Associate Professor at University of California San Diego Health, in the press ...

The European Commission has approved BridgeBio's acoramidis for life-threatening heart disorder transthyretin amyloidosis cardiomyopathy (ATTR-CM), setting up a market clash with Pfizer. The oral drug ...

Despite a sceptical appraisal by FDA reviewers, Alnylam's Onpattro has been recommended for approval as a treatment for transthyretin amyloidosis cardiomyopathy (ATTR-CM) by the regulator's advisors.